BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 35057817)

  • 1. The use of exhaled air analysis in discriminating interstitial lung diseases: a pilot study.
    Plantier L; Smolinska A; Fijten R; Flamant M; Dallinga J; Mercadier JJ; Pachen D; d'Ortho MP; van Schooten FJ; Crestani B; Boots AW
    Respir Res; 2022 Jan; 23(1):12. PubMed ID: 35057817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of multiple-flows exhaled nitric oxide in idiopathic and non-idiopathic interstitial lung disease.
    Cameli P; Bargagli E; Bergantini L; Refini RM; Pieroni M; Sestini P; Rottoli P
    J Breath Res; 2019 Mar; 13(2):026008. PubMed ID: 30690441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the Ability of Electronic Nose Technology to Recognize Interstitial Lung Diseases (ILD) by Non-Invasive Breath Screening of Exhaled Volatile Compounds (VOC): A Pilot Study from the European IPF Registry (eurIPFreg) and Biobank.
    Krauss E; Haberer J; Maurer O; Barreto G; Drakopanagiotakis F; Degen M; Seeger W; Guenther A
    J Clin Med; 2019 Oct; 8(10):. PubMed ID: 31623141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma LTBP2 as a potential biomarker in differential diagnosis of connective tissue disease-associated interstitial lung disease and idiopathic pulmonary fibrosis: a pilot study.
    Zou M; Hu X; Song W; Gao H; Wu C; Zheng W; Cheng Z
    Clin Exp Med; 2023 Dec; 23(8):4809-4816. PubMed ID: 37864077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can exhaled nitric oxide differentiate causes of pulmonary fibrosis?
    Guilleminault L; Saint-Hilaire A; Favelle O; Caille A; Boissinot E; Henriet AC; Diot P; Marchand-Adam S
    Respir Med; 2013 Nov; 107(11):1789-96. PubMed ID: 24011803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CT Features of the Usual Interstitial Pneumonia Pattern: Differentiating Connective Tissue Disease-Associated Interstitial Lung Disease From Idiopathic Pulmonary Fibrosis.
    Chung JH; Cox CW; Montner SM; Adegunsoye A; Oldham JM; Husain AN; Vij R; Noth I; Lynch DA; Strek ME
    AJR Am J Roentgenol; 2018 Feb; 210(2):307-313. PubMed ID: 29140119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiopathic Interstitial Pneumonia Associated With Autoantibodies: A Large Case Series Followed Over 1 Year.
    Collins BF; Spiekerman CF; Shaw MA; Ho LA; Hayes J; Spada CA; Stamato CM; Raghu G
    Chest; 2017 Jul; 152(1):103-112. PubMed ID: 28300570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of clinical courses and mortality of connective tissue disease-associated interstitial pneumonias and chronic fibrosing idiopathic interstitial pneumonias.
    Yıldırım F; Türk M; Bitik B; Erbaş G; Köktürk N; Haznedaroğlu Ş; Türktaş H
    Kaohsiung J Med Sci; 2019 Jun; 35(6):365-372. PubMed ID: 30913371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of characteristics of connective tissue disease-associated interstitial lung diseases, undifferentiated connective tissue disease-associated interstitial lung diseases, and idiopathic pulmonary fibrosis in Chinese Han population: a retrospective study.
    Pan L; Liu Y; Sun R; Fan M; Shi G
    Clin Dev Immunol; 2013; 2013():121578. PubMed ID: 24171031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Rcn3 level is a potential diagnostic biomarker for connective tissue disease-associated interstitial lung disease and reflects the severity of pulmonary function.
    Ding F; Yang L; Wang Y; Wang J; Ma Y; Jin J
    BMC Pulm Med; 2023 Feb; 23(1):68. PubMed ID: 36800954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum B cell-activating factor (BAFF) level in connective tissue disease associated interstitial lung disease.
    Hamada T; Samukawa T; Kumamoto T; Hatanaka K; Tsukuya G; Yamamoto M; Machida K; Watanabe M; Mizuno K; Higashimoto I; Inoue Y; Inoue H
    BMC Pulm Med; 2015 Sep; 15():110. PubMed ID: 26424433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of nailfold capillaroscopy in interstitial lung diseases - can it differentiate idiopathic cases from collagen tissue disease associated interstitial lung diseases?
    Çakmakçı Karadoğan D; Balkarlı A; Önal Ö; Altınışık G; Çobankara V
    Tuberk Toraks; 2015; 63(1):22-30. PubMed ID: 25849052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of primary graft dysfunction following lung transplantation in selected adults with connective tissue disease-associated interstitial lung disease.
    Natalini JG; Diamond JM; Porteous MK; Lederer DJ; Wille KM; Weinacker AB; Orens JB; Shah PD; Lama VN; McDyer JF; Snyder LD; Hage CA; Singer JP; Ware LB; Cantu E; Oyster M; Kalman L; Christie JD; Kawut SM; Bernstein EJ
    J Heart Lung Transplant; 2021 May; 40(5):351-358. PubMed ID: 33637413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exhaled volatile organic compounds analysis by e-nose can detect idiopathic pulmonary fibrosis.
    Dragonieri S; Scioscia G; Quaranta VN; Carratu P; Venuti MP; Falcone M; Carpagnano GE; Foschino Barbaro MP; Resta O; Lacedonia D
    J Breath Res; 2020 Jul; 14(4):047101. PubMed ID: 32320958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study.
    Cao M; Sheng J; Qiu X; Wang D; Wang D; Wang Y; Xiao Y; Cai H
    BMC Pulm Med; 2019 Nov; 19(1):215. PubMed ID: 31727051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exhaled breath analysis by use of eNose technology: a novel diagnostic tool for interstitial lung disease.
    Moor CC; Oppenheimer JC; Nakshbandi G; Aerts JGJV; Brinkman P; Maitland-van der Zee AH; Wijsenbeek MS
    Eur Respir J; 2021 Jan; 57(1):. PubMed ID: 32732331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computed Tomography Honeycombing Identifies a Progressive Fibrotic Phenotype with Increased Mortality across Diverse Interstitial Lung Diseases.
    Adegunsoye A; Oldham JM; Bellam SK; Montner S; Churpek MM; Noth I; Vij R; Strek ME; Chung JH
    Ann Am Thorac Soc; 2019 May; 16(5):580-588. PubMed ID: 30653927
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum S1P level in interstitial lung disease (ILD) is a potential biomarker reflecting the severity of pulmonary function.
    Ding F; Wang Z; Wang J; Ma Y; Jin J
    BMC Pulm Med; 2024 Jun; 24(1):266. PubMed ID: 38835000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Volatile Organic Compounds in Exhaled Breath of Idiopathic Pulmonary Fibrosis for Discrimination from Healthy Subjects.
    Yamada YI; Yamada G; Otsuka M; Nishikiori H; Ikeda K; Umeda Y; Ohnishi H; Kuronuma K; Chiba H; Baumbach JI; Takahashi H
    Lung; 2017 Apr; 195(2):247-254. PubMed ID: 28247041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo probe-based confocal laser endomicroscopy in chronic interstitial lung diseases: Specific descriptors and correlation with chest CT.
    Salaün M; Guisier F; Dominique S; Genevois A; Jounieaux V; Bergot E; Thill C; Piton N; Thiberville L
    Respirology; 2019 Aug; 24(8):783-791. PubMed ID: 30811085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.